International Ledless Pacemaker Registry (i-LEAPER)

Luigi Sacco University Hospital

Status: Enrolling

Conditions: Atrial Fibrillation; Block Complete Heart

Treatments: Device: Leadless Pacemaker (Micra)

Study type: Observational

Funder types: Other

Identifiers

NCT05528029

Hsacco2022

Details and patient eligibility

About

The Micra MC1VR01 or Micra AVMC1AVR1 Transcatheter Pacing System (Medtronic, Inc., Minneapolis, MN, USA) has become a major breakthrough as an alternative to standard transvenous pacemakers.

The aim of this multi-center study is to assess the clinical outcomes of patients implanted with Micra LLPM in real life, in different clinical scenarios.

Full description

The study includes consecutive patients implanted with a pacemaker leadless device (Micra Transcatheter Pacing System; Medtronic, Inc., Minneapolis, MN, USA).

Baselines characteristics, procedural and clinical outcomes will be collected and analyzed.

Enrollment: 2,000 estimated patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: All patients implanted with the MIcra leadless pacing system

• At least 1 month of follow up
• At least 1 post-implantation assessment, in accordance to the routine clinical practice of every center

Exclusion Criteria:

• None